Digital Therapeutics Platforms for Mental Health are clinical evidence-based treatments delivered using digital technology. They usually combine software applications, mobile applications, virtual reality, biosensors and other technologies to provide users with personalized mental health management programs and treatment services.
Digital Therapeutics Platforms for Mental Health typically include functions such as psychological assessment and screening, cognitive behavioral therapy (CBT), stress management and relaxation techniques, sleep management, biofeedback and sensor technology, online therapy and support.
The global Digital Therapeutics Platforms for Mental Health market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淒igital Therapeutics Platforms for Mental Health Industry Forecast鈥� looks at past sales and reviews total world Digital Therapeutics Platforms for Mental Health sales in 2022, providing a comprehensive analysis by region and market sector of projected Digital Therapeutics Platforms for Mental Health sales for 2023 through 2029. With Digital Therapeutics Platforms for Mental Health sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Digital Therapeutics Platforms for Mental Health industry.
This Insight Report provides a comprehensive analysis of the global Digital Therapeutics Platforms for Mental Health landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Digital Therapeutics Platforms for Mental Health portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Digital Therapeutics Platforms for Mental Health market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Digital Therapeutics Platforms for Mental Health and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Digital Therapeutics Platforms for Mental Health.
United States market for Digital Therapeutics Platforms for Mental Health is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Digital Therapeutics Platforms for Mental Health is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Digital Therapeutics Platforms for Mental Health is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Digital Therapeutics Platforms for Mental Health players cover Akili Interactive, Teladoc Health, Talkspace, CogniFit, Orexo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Digital Therapeutics Platforms for Mental Health market by product type, application, key players and key regions and countries.
Segmentation by Type:
Apps
Online Platforms
Segmentation by Application:
Enterprise
Personal
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Apps
Online Platforms
Segmentation by Application:
Enterprise
Personal
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Akili Interactive
Teladoc Health
Talkspace
CogniFit
Orexo
SilverCloud (Amwell)
Noom
Big Health
Cognoa
Headspace Health
Calm Health
Lark Health
Vida Health
Mahana Therapeutics
Blue Note Therapeutics
Lyra Health
Modern Health
Canary Health
Woebot Health
LifeStance Health
Cerebral
MoodMission
Youper
Best Covered
Dami and Xiaomi
WeiMai
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Digital Therapeutics Platforms for Mental Health 麻豆原创 Size 2019-2030
2.1.2 Digital Therapeutics Platforms for Mental Health 麻豆原创 Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Digital Therapeutics Platforms for Mental Health by Country/Region, 2019, 2023 & 2030
2.2 Digital Therapeutics Platforms for Mental Health Segment by Type
2.2.1 Apps
2.2.2 Online Platforms
2.3 Digital Therapeutics Platforms for Mental Health 麻豆原创 Size by Type
2.3.1 Digital Therapeutics Platforms for Mental Health 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Digital Therapeutics Platforms for Mental Health 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Digital Therapeutics Platforms for Mental Health Segment by Application
2.4.1 Enterprise
2.4.2 Personal
2.5 Digital Therapeutics Platforms for Mental Health 麻豆原创 Size by Application
2.5.1 Digital Therapeutics Platforms for Mental Health 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Digital Therapeutics Platforms for Mental Health 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Digital Therapeutics Platforms for Mental Health 麻豆原创 Size by Player
3.1 Digital Therapeutics Platforms for Mental Health 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Digital Therapeutics Platforms for Mental Health Revenue by Player (2019-2024)
3.1.2 Global Digital Therapeutics Platforms for Mental Health Revenue 麻豆原创 Share by Player (2019-2024)
3.2 Global Digital Therapeutics Platforms for Mental Health Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Digital Therapeutics Platforms for Mental Health by Region
4.1 Digital Therapeutics Platforms for Mental Health 麻豆原创 Size by Region (2019-2024)
4.2 Global Digital Therapeutics Platforms for Mental Health Annual Revenue by Country/Region (2019-2024)
4.3 Americas Digital Therapeutics Platforms for Mental Health 麻豆原创 Size Growth (2019-2024)
4.4 APAC Digital Therapeutics Platforms for Mental Health 麻豆原创 Size Growth (2019-2024)
4.5 Europe Digital Therapeutics Platforms for Mental Health 麻豆原创 Size Growth (2019-2024)
4.6 Middle East & Africa Digital Therapeutics Platforms for Mental Health 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Digital Therapeutics Platforms for Mental Health 麻豆原创 Size by Country (2019-2024)
5.2 Americas Digital Therapeutics Platforms for Mental Health 麻豆原创 Size by Type (2019-2024)
5.3 Americas Digital Therapeutics Platforms for Mental Health 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Digital Therapeutics Platforms for Mental Health 麻豆原创 Size by Region (2019-2024)
6.2 APAC Digital Therapeutics Platforms for Mental Health 麻豆原创 Size by Type (2019-2024)
6.3 APAC Digital Therapeutics Platforms for Mental Health 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Digital Therapeutics Platforms for Mental Health 麻豆原创 Size by Country (2019-2024)
7.2 Europe Digital Therapeutics Platforms for Mental Health 麻豆原创 Size by Type (2019-2024)
7.3 Europe Digital Therapeutics Platforms for Mental Health 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Digital Therapeutics Platforms for Mental Health by Region (2019-2024)
8.2 Middle East & Africa Digital Therapeutics Platforms for Mental Health 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Digital Therapeutics Platforms for Mental Health 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Digital Therapeutics Platforms for Mental Health 麻豆原创 Forecast
10.1 Global Digital Therapeutics Platforms for Mental Health Forecast by Region (2025-2030)
10.1.1 Global Digital Therapeutics Platforms for Mental Health Forecast by Region (2025-2030)
10.1.2 Americas Digital Therapeutics Platforms for Mental Health Forecast
10.1.3 APAC Digital Therapeutics Platforms for Mental Health Forecast
10.1.4 Europe Digital Therapeutics Platforms for Mental Health Forecast
10.1.5 Middle East & Africa Digital Therapeutics Platforms for Mental Health Forecast
10.2 Americas Digital Therapeutics Platforms for Mental Health Forecast by Country (2025-2030)
10.2.1 United States 麻豆原创 Digital Therapeutics Platforms for Mental Health Forecast
10.2.2 Canada 麻豆原创 Digital Therapeutics Platforms for Mental Health Forecast
10.2.3 Mexico 麻豆原创 Digital Therapeutics Platforms for Mental Health Forecast
10.2.4 Brazil 麻豆原创 Digital Therapeutics Platforms for Mental Health Forecast
10.3 APAC Digital Therapeutics Platforms for Mental Health Forecast by Region (2025-2030)
10.3.1 China Digital Therapeutics Platforms for Mental Health 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Digital Therapeutics Platforms for Mental Health Forecast
10.3.3 Korea 麻豆原创 Digital Therapeutics Platforms for Mental Health Forecast
10.3.4 Southeast Asia 麻豆原创 Digital Therapeutics Platforms for Mental Health Forecast
10.3.5 India 麻豆原创 Digital Therapeutics Platforms for Mental Health Forecast
10.3.6 Australia 麻豆原创 Digital Therapeutics Platforms for Mental Health Forecast
10.4 Europe Digital Therapeutics Platforms for Mental Health Forecast by Country (2025-2030)
10.4.1 Germany 麻豆原创 Digital Therapeutics Platforms for Mental Health Forecast
10.4.2 France 麻豆原创 Digital Therapeutics Platforms for Mental Health Forecast
10.4.3 UK 麻豆原创 Digital Therapeutics Platforms for Mental Health Forecast
10.4.4 Italy 麻豆原创 Digital Therapeutics Platforms for Mental Health Forecast
10.4.5 Russia 麻豆原创 Digital Therapeutics Platforms for Mental Health Forecast
10.5 Middle East & Africa Digital Therapeutics Platforms for Mental Health Forecast by Region (2025-2030)
10.5.1 Egypt 麻豆原创 Digital Therapeutics Platforms for Mental Health Forecast
10.5.2 South Africa 麻豆原创 Digital Therapeutics Platforms for Mental Health Forecast
10.5.3 Israel 麻豆原创 Digital Therapeutics Platforms for Mental Health Forecast
10.5.4 Turkey 麻豆原创 Digital Therapeutics Platforms for Mental Health Forecast
10.6 Global Digital Therapeutics Platforms for Mental Health Forecast by Type (2025-2030)
10.7 Global Digital Therapeutics Platforms for Mental Health Forecast by Application (2025-2030)
10.7.1 GCC Countries 麻豆原创 Digital Therapeutics Platforms for Mental Health Forecast
11 Key Players Analysis
11.1 Akili Interactive
11.1.1 Akili Interactive Company Information
11.1.2 Akili Interactive Digital Therapeutics Platforms for Mental Health Product Offered
11.1.3 Akili Interactive Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Akili Interactive Main Business Overview
11.1.5 Akili Interactive Latest Developments
11.2 Teladoc Health
11.2.1 Teladoc Health Company Information
11.2.2 Teladoc Health Digital Therapeutics Platforms for Mental Health Product Offered
11.2.3 Teladoc Health Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Teladoc Health Main Business Overview
11.2.5 Teladoc Health Latest Developments
11.3 Talkspace
11.3.1 Talkspace Company Information
11.3.2 Talkspace Digital Therapeutics Platforms for Mental Health Product Offered
11.3.3 Talkspace Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Talkspace Main Business Overview
11.3.5 Talkspace Latest Developments
11.4 CogniFit
11.4.1 CogniFit Company Information
11.4.2 CogniFit Digital Therapeutics Platforms for Mental Health Product Offered
11.4.3 CogniFit Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 CogniFit Main Business Overview
11.4.5 CogniFit Latest Developments
11.5 Orexo
11.5.1 Orexo Company Information
11.5.2 Orexo Digital Therapeutics Platforms for Mental Health Product Offered
11.5.3 Orexo Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Orexo Main Business Overview
11.5.5 Orexo Latest Developments
11.6 SilverCloud (Amwell)
11.6.1 SilverCloud (Amwell) Company Information
11.6.2 SilverCloud (Amwell) Digital Therapeutics Platforms for Mental Health Product Offered
11.6.3 SilverCloud (Amwell) Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 SilverCloud (Amwell) Main Business Overview
11.6.5 SilverCloud (Amwell) Latest Developments
11.7 Noom
11.7.1 Noom Company Information
11.7.2 Noom Digital Therapeutics Platforms for Mental Health Product Offered
11.7.3 Noom Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Noom Main Business Overview
11.7.5 Noom Latest Developments
11.8 Big Health
11.8.1 Big Health Company Information
11.8.2 Big Health Digital Therapeutics Platforms for Mental Health Product Offered
11.8.3 Big Health Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Big Health Main Business Overview
11.8.5 Big Health Latest Developments
11.9 Cognoa
11.9.1 Cognoa Company Information
11.9.2 Cognoa Digital Therapeutics Platforms for Mental Health Product Offered
11.9.3 Cognoa Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Cognoa Main Business Overview
11.9.5 Cognoa Latest Developments
11.10 Headspace Health
11.10.1 Headspace Health Company Information
11.10.2 Headspace Health Digital Therapeutics Platforms for Mental Health Product Offered
11.10.3 Headspace Health Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Headspace Health Main Business Overview
11.10.5 Headspace Health Latest Developments
11.11 Calm Health
11.11.1 Calm Health Company Information
11.11.2 Calm Health Digital Therapeutics Platforms for Mental Health Product Offered
11.11.3 Calm Health Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Calm Health Main Business Overview
11.11.5 Calm Health Latest Developments
11.12 Lark Health
11.12.1 Lark Health Company Information
11.12.2 Lark Health Digital Therapeutics Platforms for Mental Health Product Offered
11.12.3 Lark Health Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Lark Health Main Business Overview
11.12.5 Lark Health Latest Developments
11.13 Vida Health
11.13.1 Vida Health Company Information
11.13.2 Vida Health Digital Therapeutics Platforms for Mental Health Product Offered
11.13.3 Vida Health Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Vida Health Main Business Overview
11.13.5 Vida Health Latest Developments
11.14 Mahana Therapeutics
11.14.1 Mahana Therapeutics Company Information
11.14.2 Mahana Therapeutics Digital Therapeutics Platforms for Mental Health Product Offered
11.14.3 Mahana Therapeutics Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 Mahana Therapeutics Main Business Overview
11.14.5 Mahana Therapeutics Latest Developments
11.15 Blue Note Therapeutics
11.15.1 Blue Note Therapeutics Company Information
11.15.2 Blue Note Therapeutics Digital Therapeutics Platforms for Mental Health Product Offered
11.15.3 Blue Note Therapeutics Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 Blue Note Therapeutics Main Business Overview
11.15.5 Blue Note Therapeutics Latest Developments
11.16 Lyra Health
11.16.1 Lyra Health Company Information
11.16.2 Lyra Health Digital Therapeutics Platforms for Mental Health Product Offered
11.16.3 Lyra Health Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.16.4 Lyra Health Main Business Overview
11.16.5 Lyra Health Latest Developments
11.17 Modern Health
11.17.1 Modern Health Company Information
11.17.2 Modern Health Digital Therapeutics Platforms for Mental Health Product Offered
11.17.3 Modern Health Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.17.4 Modern Health Main Business Overview
11.17.5 Modern Health Latest Developments
11.18 Canary Health
11.18.1 Canary Health Company Information
11.18.2 Canary Health Digital Therapeutics Platforms for Mental Health Product Offered
11.18.3 Canary Health Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.18.4 Canary Health Main Business Overview
11.18.5 Canary Health Latest Developments
11.19 Woebot Health
11.19.1 Woebot Health Company Information
11.19.2 Woebot Health Digital Therapeutics Platforms for Mental Health Product Offered
11.19.3 Woebot Health Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.19.4 Woebot Health Main Business Overview
11.19.5 Woebot Health Latest Developments
11.20 LifeStance Health
11.20.1 LifeStance Health Company Information
11.20.2 LifeStance Health Digital Therapeutics Platforms for Mental Health Product Offered
11.20.3 LifeStance Health Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.20.4 LifeStance Health Main Business Overview
11.20.5 LifeStance Health Latest Developments
11.21 Cerebral
11.21.1 Cerebral Company Information
11.21.2 Cerebral Digital Therapeutics Platforms for Mental Health Product Offered
11.21.3 Cerebral Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.21.4 Cerebral Main Business Overview
11.21.5 Cerebral Latest Developments
11.22 MoodMission
11.22.1 MoodMission Company Information
11.22.2 MoodMission Digital Therapeutics Platforms for Mental Health Product Offered
11.22.3 MoodMission Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.22.4 MoodMission Main Business Overview
11.22.5 MoodMission Latest Developments
11.23 Youper
11.23.1 Youper Company Information
11.23.2 Youper Digital Therapeutics Platforms for Mental Health Product Offered
11.23.3 Youper Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.23.4 Youper Main Business Overview
11.23.5 Youper Latest Developments
11.24 Best Covered
11.24.1 Best Covered Company Information
11.24.2 Best Covered Digital Therapeutics Platforms for Mental Health Product Offered
11.24.3 Best Covered Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.24.4 Best Covered Main Business Overview
11.24.5 Best Covered Latest Developments
11.25 Dami and Xiaomi
11.25.1 Dami and Xiaomi Company Information
11.25.2 Dami and Xiaomi Digital Therapeutics Platforms for Mental Health Product Offered
11.25.3 Dami and Xiaomi Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.25.4 Dami and Xiaomi Main Business Overview
11.25.5 Dami and Xiaomi Latest Developments
11.26 WeiMai
11.26.1 WeiMai Company Information
11.26.2 WeiMai Digital Therapeutics Platforms for Mental Health Product Offered
11.26.3 WeiMai Digital Therapeutics Platforms for Mental Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.26.4 WeiMai Main Business Overview
11.26.5 WeiMai Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.